The present work aims to study the molecular mechanisms of hyperglycemia-mediated mitochondrial dysfunction and its regulation through pharmacological and genetic suppression of VDAC1 activity in primary endotheliocyte and fibroblast cell cultures. This evidence concerns the gene VDAC1 and Hyperglycemia.